Stanik, J <br/><br/>
Sulfonylurea vs insulin therapy in individuals with sulfonylurea-sensitive permanent neonatal diabetes mellitus, attributable to a KCNJ11 mutation, and poor glycaemic control.  [electronic resource] 

 -  Diabetic medicine : a journal of the British Diabetic Association  03 2018 
 - 386-391 p.  digital 
<br/><br/> Publication Type: Case Reports; Comparative Study; Research Support, Non-U.S. Gov't; Journal Article 
<br/><br/><label>ISSN: </label>1464-5491 
<br/><br/><label>Standard No.: </label>10.1111/dme.13575  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Diabetes Mellitus--blood<br/>Drug Substitution<br/>Drug Therapy, Combination<br/>Female<br/>Glyburide--therapeutic use<br/>Glycated Hemoglobin--metabolism<br/>Humans<br/>Hypoglycemic Agents--therapeutic use<br/>Insulin--therapeutic use<br/>Male<br/>Mutation--genetics<br/>Potassium Channels, Inwardly Rectifying--genetics<br/>Young Adult